United States · FDA National Drug Code directory
Azulfidine EN-tabs
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0013-0102_f4631374-60aa-4e49-ac58-632f9cbdea08
- Product NDC
- 0013-0102
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- Sulfasalazine
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 19500620
- Source listing expiry
- 20271231
Source-listed ingredients
- SULFASALAZINE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (0013-0102-50) / 100 TABLET, DELAYED RELEASE in 1 BOTTLE · 0013-0102-50
- 1 BOTTLE in 1 CARTON (0013-0102-60) / 300 TABLET, DELAYED RELEASE in 1 BOTTLE · 0013-0102-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →